For instance, in a rabbit model of atherosclerosis, dapagliflozin demonstrated anti-atherosclerotic properties by regulating the inflammatory responses (resulting in a reduced expression of TNF-α, IL-1β, and IL-6) and promoting macrophage polarization towards M2 macrophages, even in non-diabetic conditions [59]. The gene discussed is IL1B; the disease is atherosclerosis.